36 results
8-K/A
EX-99.3
CRVO
CervoMed Inc
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
pharmaceutical product samples and impose requirements to ensure accountability in distribution. Most recently, the Drug Supply Chain Security Act (“DSCSA … of the healthcare and pharmaceutical supply chain, an important decision that may lead to further and more aggressive efforts by states in this area
8-K/A
EX-99.2
CRVO
CervoMed Inc
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
the proper technology and cybersecurity infrastructure, it could suffer significant business disruption, including transaction errors, supply chain … of the health care and pharmaceutical supply chain, an important decision that may lead to appears to be leading to further and more aggressive efforts
424B3
og5 frv41qr69ra2z8u
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
tw8ix49ffpd2bbmd
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
nb4nyafsg0vzedzt1
10 May 23
Registration of securities issued in business combination transactions
9:56pm
DEFA14A
h8af2
16 Dec 22
Additional proxy soliciting materials
5:16pm
8-K
EX-99.1
n2riwmc nm
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
DEFA14A
EX-99.1
g0k8qr7auuq7vy p0
5 Dec 22
Additional proxy soliciting materials
9:59pm
8-K
EX-99.1
l2ul qre22ofz5a
5 Dec 22
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process
9:58pm
8-K
EX-99.1
2agkyzji1 f6jd5nv
18 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
4:40pm
DEFA14A
EX-99.1
slzdi
14 Nov 22
Additional proxy soliciting materials
7:41am
8-K
EX-99.1
hs3yr5oh5k7
14 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
7:40am
8-K
EX-99.1
pwwhc7e
27 Oct 22
Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
4:15pm
8-K
EX-99.1
3ficn0r177
16 Aug 22
Diffusion Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
4:21pm
8-K
EX-99.1
9p1xsj5p5k4hbyrdgf5i
27 Jul 22
Other Events
7:30am
8-K
EX-99.1
navfxzx 4sfsek7h2j
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm